Cerenome, Inc.

US$0.64As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CNSYHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (73.11%)
Div yield —
ROE (614.05%)
Biotechnology
Beta (5Y) 1.47
PE TTM —
TSR TTM (95.27%)
Mkt cap US$4.878M
ROIC (385.02%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.62
(3.60%)
273.38%
Hold 9|11|12|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
14.53%
12.92%
13.24%
13.66%
Revenue$M
0.324
0.343
0.335
0.326
7.24%
12.94%
8.67%
(0.17%)
Peers (US$4.878M)
Cap (US$)
PE
4.741M
—
4.895M
—
Capital
TTM
5Y
10Y
Leveragex
2.148
0.466
0.334
EBIT/Intx
0.413
0.063
0.085
Own earn%
21.77
70.12
53.47
Sh yield%
31.71
32.26
35.84
Owners
Insiders/Inst%
1.04
26.57
Short interest%
2.25
SBC / revenue%
3.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
1